Patients with the transposition of great arteries (TGA) who undergo atrial switch operation and congenitally corrected TGA (ccTGA) patients have the right ventricle as their systemic ventricle. Function of the systemic right ventricle (SRV) could deteriorate which is associated with impaired prognosis. It is of paramount importance to understand the course and fate of these patients during a long-term follow-up to identify the determinants of adverse outcomes.
Age range
12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
All-cause mortality
Timeframe: Through study completion, an average of 18 years
Incident heart failure
Timeframe: Through study completion, an average of 18 years
Number of patients with heart failure hospitalization
Timeframe: Through study completion, an average of 18 years
Number of patients with arrhythmias
Timeframe: Through study completion, an average of 18 years
Number of patients with thromboembolic events
Timeframe: Through study completion, an average of 18 years
Infective endocarditis
Timeframe: Through study completion, an average of 18 years
Number of patients with tricuspid valve surgery
Timeframe: Through study completion, an average of 18 years
Number of patients with ventricular Assist Device implantation
Timeframe: Through study completion, an average of 18 years
Number of patients with heart transplantation
Timeframe: Through study completion, an average of 18 years
Number of patients with aortic aneurysm or dissection
Timeframe: Through study completion, an average of 18 years
Number of patients with pulmonary artery hypertension
Timeframe: Through study completion, an average of 18 years
Number of patients with baffle interventions
Timeframe: Through study completion, an average of 18 years
Number of patients with coronary artery interventions
Timeframe: Through study completion, an average of 18 years
Number of patients with device implantation
Timeframe: Through study completion, an average of 18 years